Trial
NCT04391309
COVID-19 and Anti-CD14 Treatment Trial
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
University of Washington; Implicit Bioscience; Vanderbilt University Medical Center; PPD Development, LP
Condition
Coronavirus Disease 2019 (COVID-19)
Intervention
anti-CD14
Why stopped
Stopped to slow rate of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-26